Schedule 13G ownership disclosure

SCOPUS BIOPHARMA INC

Security class unavailable · CUSIP: 809171101

Event date: 2021-06-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
911,079
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-091353
Form type
SC 13G
Filer
Kortylewski Marcin
CIK
CIK 1871978
Filed
Jul 13, 2021
Reporting period
Jun 25, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub